Matthew S Milak
Datos Biográficos
| ID | 7675615 |
|---|---|
| NOMBRE | Matthew S Milak |
| NOMBRES | Matthew S |
| APELLIDO | Milak |
| FIRMA | MILAK M S |
| AFILIACIONES | Columbia University |
| ORCID | 0000-0003-3717-7056 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2021 |
| ÍNDICE H | 0 |
Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression
N-methyl-D-aspartate glutamate-receptor (NMDAR) antagonists such as ketamine have demonstrated efficacy in both major depressive disorder (MDD) and bipolar disorder depression (BP-D). We have previously reported that reduction in Glx (glutamate + glutamine) in the ventromedial prefrontal cortex/anterior cingulate cortex (vmPFC/ACC), measured by proton magnetic resonance spectroscopy ( 1 H MRS) at 3T during a ketamine infusion, mediates the relati…
Sin obras prominentes en esta página.
Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression
N-methyl-D-aspartate glutamate-receptor (NMDAR) antagonists such as ketamine have demonstrated efficacy in both major depressive disorder (MDD) and bipolar disorder depression (BP-D). We have previously reported that reduction in Glx (glutamate + glutamine) in the ventromedial prefrontal cortex/anterior cingulate cortex (vmPFC/ACC), measured by proton magnetic resonance spectroscopy ( 1 H MRS) at 3T during a ketamine infusion, mediates the relati…
Agonist (1 obra) · Amygdala (1 obra) · Anesthesia (1 obra) · Anterior cingulate cortex (1 obra) · Antidepressant (1 obra) · Antipsychotic (1 obra) · Aripiprazole (1 obra) · Bipolar disorder (1 obra) · Bipolar Disorder and Treatment (1 obra) · Escitalopram (1 obra)